Viroad Biotechnology

Viroad is a pioneering company specializing in the development of innovative in vivo devices designed to capture circulating tumor cells (CTCs) from blood samples. Operating in the medical technology sector, Viroad serves healthcare providers, research institutions, and oncology specialists who require advanced tools for early-stage cancer detection. The company's flagship product, CellCollector, is a medical guidewire coated with anti-EpCAM antibodies that can capture CTCs directly from a patient's bloodstream. This device has demonstrated efficacy in detecting CTCs in patients with breast cancer and non-small cell lung cancer (NSCLC), including those in early, non-metastatic stages. Viroad's business model revolves around the sale and distribution of these specialized medical devices, generating revenue through direct sales to hospitals and clinics, as well as through partnerships with research organizations. By addressing the limitations of traditional micro devices in detecting rare CTCs, Viroad aims to enhance early cancer diagnosis and improve patient outcomes.

Keywords: circulating tumor cells, early-stage cancer, in vivo devices, medical technology, oncology, CellCollector, anti-EpCAM antibodies, breast cancer, NSCLC, healthcare innovation.